Abbvie Inc at Wolfe Research Inaugural Healthcare Conference Transcript
All right. Good. Well, thank you for joining us for this session. We're up here with management from AbbVie, 3 members of the management team. Rick Gonzalez, who's the CEO and Chairman of the Board. He spent more than 30 years at Abbott and then later AbbVie, working in a variety of roles, commercial, R&D, manufacturing, being the big boss of the company. Mike Severino as well. He's Vice Chairman, President of AbbVie, responsible for R&D and other expanded roles within the organization. He joined the company in 2014. Prior to that, he was at Amgen and also Merck for a number of years. And Rob Michael, who's Executive Vice President and Chief Financial Officer. Prior to that, he held a variety of roles, both within AbbVie and the predecessor company, Abbott, where he joined in 1993.
So with this list of speakers, we can cover a lot of ground here, which is great. I thought maybe we'd start off talking about something that's timely and topical, not oncology yet and the data that came up. But we're going to talk about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

